-
St. Jude Comprehensive Cancer Center receives its third consecutive ‘Exceptional’ rating from the National Cancer Institute
09/29/2025
National Cancer Institute renews St. Jude Comprehensive Cancer Center designation
-
Inactive H5N1 influenza virus in pasteurized milk poses minimal health risks
09/26/2025
Explore St. Jude research testing if dead H5N1 influenza virus pieces in milk alter immunity & how pre-existing flu immunity affects H5N1 infection from milk.
-
Screening approach enhances CRISPR genome-editing efficiency
09/23/2025
See how thousands of genome-editing CRISPR transposons were screened rapidly for efficiency highlighting route for bioengineering strategies
-
Lipids drive activation of the cellular degradation system LC3-associated phagocytosis
09/22/2025
See how a lipid triggers LC3-associated phagocytosis, providing the first evidence that lipids play a regulatory role in this cellular degradation process.
-
‘Molecular glue’ harnesses the power of the immune system to treat neuroblastoma
09/17/2025
See how neuroblastoma cells can switch cell state to avoid therapy and how molecular glue indisulam and immunotherapy negates this
-
New multi-disciplinary approach sheds light on the role of mitochondrial DNA mutations in cancer
09/10/2025
See how mitochondrial DNA mutations lead to leukemogenesis despite heteroplasmy and contribute to functional heterogeneity
-
Research implicates biomolecular condensates in a type of childhood brain cancer
08/27/2025
Discover research showing that small disordered regions of a fusion protein creates droplets called condensates that are essential to ependymoma development.
-
Midkine protein plays a preventive role against Alzheimer’s disease
08/21/2025
See how midkine inhibits amyloid beta fibrils in Alzheimer’s disease with potential discovery implications with therapeutic benefits
-
Clinical trial shows newborns with spinal muscular atrophy (SMA) can start treatment at birth
08/13/2025
Explore the results of a phase 2 clinical trial showing that presymptomatic newborns destined to have SMA can be safely & effectively treated with risdiplam.
-
AI-informed approach to CAR design enhances bi-specific CAR T cells
08/13/2025
Discover a computational method from St. Jude that screens theoretical chimeric antigen receptor (CAR) designs & optimizes them, which they validated in vivo.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.